CJD Research
Creutzfeldt-Jakob disease (CJD) is a rare illness which affects both humans and animals. CJD is progressive, currently untreatable and ultimately fatal. Research is vital.
Creutzfeldt-Jakob disease (CJD) is a rare illness which affects both humans and animals. CJD is progressive, currently untreatable and ultimately fatal. Research is vital.
CJD (Creutzfeldt-Jakob Disease) is a rare illness and is one of a group of diseases called prion diseases, which affect humans and animals. Prion diseases exist in different forms, all of which are progressive, currently untreatable and ultimately fatal. Their name arises because they are associated with an alteration in a naturally occurring protein: the prion protein.
CJD was first described in 1920. The commonest form is called sporadic CJD and occurs worldwide causing around 1-2 deaths per million population per year. A new form of CJD (variant CJD) linked to bovine spongiform encephalopathy (BSE) in cattle was identified in 1996. There are also genetic forms of human prion disease linked to mutations of the prion protein gene and cases caused by infection via medical or surgical treatments (iatrogenic CJD).
Investigators at the University of Edinburgh’s Centre for Clinical Brain Sciences (CCBS) are studying the causes, consequences and treatment of major brain disorders. Working collaboratively, CCBS members undertake fundamental and clinical research into neurological disorders, also playing a key role in translating research findings into benefits for patients.
The University of Edinburgh Development Trust administers all donations in aid of the University of Edinburgh, including the Centre for Clinical Brain Sciences. The Development Trust will administer your donation and ensure 100% of your donation supports CJD research.
Thank you for supporting CJD research.
* Charities pay a small fee for our service. Find out how much it is and what we do for it.